Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Decision Diagnostics Corp (DECN) Message Board

These distributor networks are an important first

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 11803
(Total Views: 477)
Posted On: 10/28/2020 2:19:51 PM
Posted By: DirkEaston
Re: gman3 #11302
These distributor networks are an important first step. I would think that the company expects a CE Mark sooner than the FDA EUA, so having overseas distribution set up ahead of time will give them a big head start.

Of course, it would be a huge benefit for DECN to obtain the FDA EUA around the same time as the CE Mark. That would explain the talks with US based distributors. With a CE Mark alone I believe DECN would be approached by quite a few manufacturing partners to help fill all the orders. Throw in an EUA from the FDA and it's balls to the wall.

By the sounds of it, the testing for GenViro! Saliva is going well. That's great news. And, as we all know, the testing is being performed by an "FDA and CLIA certified US-based testing partner". This is an important point. These guys are the real deal.

Quote:
Late last month the company announced it had signed an agreement with an FDA and CLIA certified US-based testing partner to undertake a feasibility study together with required testing for FDA EUA and European Union CE Mark certification as well as with the Russian Federation for submission of the GenViro! Covid-19 Saliva Swift Kit. The lab results will be included in DECN's upcoming FDA EUA applications which are expected to be filed in Q4 2020. The company plans for parallel applications with the EU and Russian Federation, as it continues its international efforts to make its detection technology available globally.



(1)
(0)




Decision Diagnostics Corp (DECN) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us